Prelude Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-57,497
Closed -$1.34M 1441
2024
Q3
$1.34M Sell
57,497
-10,139
-15% -$237K 0.08% 268
2024
Q2
$1.2M Buy
67,636
+12,036
+22% +$214K 0.08% 248
2024
Q1
$846K Buy
55,600
+6,800
+14% +$103K 0.04% 393
2023
Q4
$834K Sell
48,800
-9,952
-17% -$170K 0.06% 282
2023
Q3
$491K Buy
58,752
+49,430
+530% +$413K 0.03% 388
2023
Q2
$232K Buy
+9,322
New +$232K 0.02% 673
2023
Q1
Sell
-37,127
Closed -$439K 1345
2022
Q4
$439K Sell
37,127
-900
-2% -$10.6K 0.02% 547
2022
Q3
$225K Sell
38,027
-1,947
-5% -$11.5K 0.01% 998
2022
Q2
$170K Sell
39,974
-1,677
-4% -$7.13K ﹤0.01% 1124
2022
Q1
$396K Buy
41,651
+1,823
+5% +$17.3K 0.01% 767
2021
Q4
$757K Buy
39,828
+846
+2% +$16.1K 0.02% 577
2021
Q3
$1.3M Buy
+38,982
New +$1.3M 0.03% 320
2020
Q3
Hold
0
1828
2020
Q2
Hold
0
1690
2020
Q1
Hold
0
1531
2019
Q4
Sell
-100
Closed -$1K 1754
2019
Q3
$1K Buy
+100
New +$1K ﹤0.01% 1132
2019
Q2
Hold
0
1708
2019
Q1
Sell
-73
Closed 1726
2018
Q4
$0 Buy
+73
New ﹤0.01% 1730
2018
Q3
Sell
-78
Closed -$1K 1668
2018
Q2
$1K Buy
+78
New +$1K ﹤0.01% 1316
2014
Q4
Sell
-2,007
Closed -$21K 2023
2014
Q3
$21K Buy
2,007
+1,582
+372% +$16.6K ﹤0.01% 1617
2014
Q2
$4K Sell
425
-8,580
-95% -$80.8K ﹤0.01% 1674
2014
Q1
$62K Buy
+9,005
New +$62K 0.01% 1067